Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Identification of an aprotinin antiviral domain

View through CrossRef
Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3. It consisted of the hexapeptide Y‐F‐Y‐N‐A‐K corresponding to amino acids 21–26 of intact aprotinin. An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity. Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J. Appl. Bact. 72, 180–187].
Title: Identification of an aprotinin antiviral domain
Description:
Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments.
Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity.
One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3.
It consisted of the hexapeptide Y‐F‐Y‐N‐A‐K corresponding to amino acids 21–26 of intact aprotinin.
An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity.
Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J.
Appl.
Bact.
72, 180–187].

Related Results

Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass
Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass
Background and objective: We have previously reported that administration of aprotinin at a single dose protects the cerebral microcirculation. The current study was designed to id...
Aprotinin
Aprotinin
OBJECTIVE: To review the clinical pharmacology of aprotinin in patients undergoing surgical procedures involving major blood loss, namely, coronary artery bypas...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...
The possibility of using silochrome sorbents for proteinase inhibitor aprotinin
The possibility of using silochrome sorbents for proteinase inhibitor aprotinin
Background. Aprotinin is a polypeptide, a proteinase inhibitor of natural origin. It inhibits kallikrein, kininogenase, plasmin, trypsin, chymotrypsin; blocks the activator of prof...
Aprotinin Fifteen Years Later
Aprotinin Fifteen Years Later
Aprotinin, the broad-based bovine serine protease inhibitor, was first used as an antidote against the harmful proteases released through complement-induced neutrophil activation i...
Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin
Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin
The kinetic investigation of the inhibition of human pancreatic trypsin 1, trypsin 2 and chymotrypsin A by mucus proteinase inhibitor, eglin c and aprotinin reveals that (i) the fi...

Back to Top